• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>The Open Anesthesia Journal >Dexmedetomidine in the Management of Awake Fiberoptic Intubation
【24h】

Dexmedetomidine in the Management of Awake Fiberoptic Intubation

机译：右美托咪定在清醒纤维插管的管理中

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Awake Fibreoptic Intubation (AFOI) is, nowadays, the gold standard in predicted difficult airway management. Numerous practice guidelines have been developed to assist clinicians facing with a difficult airway. If conducted without sedation, it is common that this procedure may lead to high patient discomfort and severe hemodynamic responses. Sedation is frequently used to make the process more tolerable to patients even if it is not always easy to strike a balance between patient comfort, safety, co-operation, and good intubating conditions. In the last years, many drugs and drug combinations have been described. This minireview aims to discuss the evidence supporting the use of Dexmedetomidine (DEX) in the AFOI management.
机译：如今，唤醒光纤插管（AFOI）已成为预测困难气道管理的金标准。为了帮助临床医生面对困难的气道，已经制定了许多实践指南。如果在没有镇静的情况下进行，通常会导致患者高度不适和严重的血液动力学反应。镇静经常被用于使过程对患者更具耐受性，即使在患者舒适度，安全性，合作性和良好的插管条件之间并不总是那么容易时，镇静也是如此。近年来，已经描述了许多药物和药物组合。本小型审查旨在讨论支持在AFOI管理中使用右美托咪定（DEX）的证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号